The Leaflex™ Brazilian Standalone Study

NATerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

October 3, 2022

Primary Completion Date

November 14, 2024

Study Completion Date

November 14, 2024

Conditions
Aortic Valve Stenosis
Interventions
DEVICE

Leaflex™ Performer

A transfemoral catheter designed to treat calcific aortic stenosis by scoring the calcification in the aortic valve leaflets.

Trial Locations (1)

05403-000

Instituto do Coração FMUSP Centro de Pesquisa, São Paulo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pi-cardia

INDUSTRY

NCT05052684 - The Leaflex™ Brazilian Standalone Study | Biotech Hunter | Biotech Hunter